EHPL – European Health & Pharmaceutical Law Review

EHPL 1/2025 Out Now

The first issue of the European Health & Pharmaceutical Law Review (EHPL) for 2025 is now available! This edition features a selection of thought-provoking articles and reports on critical developments in health and pharmaceutical law.

Articles:

Public versus Private Interests in Intellectual Property Rights Law: Where Does the Right to Science Stand in Cancer Research?

Exploring the balance between intellectual property protection and the right to scientific progress in cancer research.

How Can We End Drug Misuse by Properly Regulating Off-Label Drug Use in the EU: The Example of Fluoroquinolones?

An in-depth look at the risks and regulatory challenges of off-label drug use in the EU, with fluoroquinolones as a case study.

Regulatory Sandbox to Support Innovation in the Pharmaceutical Field

An examination of about how regulatory sandboxes can accelerate the development of innovative medicines by providing a controlled environment for testing, fostering collaboration between regulators and industry, and expediting patient access to treatments.

 

This issue also includes the following reports:

From Lab to Market: The EU AI Act’s Impact on Pharmaceutical AI Deployers

Supply of Investigational Medicinal Products after the Conclusion of Clinical Trials: The Times They Are A-Changin’

A New Reimbursement Law in Poland Is Forthcoming – Will It Enhance Access to Medicines?

---

Sie möchten einen Beitrag einreichen oder zur Weiterentwicklung der EHPL beitragen? Dann nutzen Sie unseren Call for Papers (englischsprachig). Weitere Details zur EHPL finden Sie auf der englischsprachigen Website.